SOCIÉTÉ ADWYA S.A More news
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Tarek Hammami
CEO | Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mounir Jerbi
BRD | Director/Board Member | - | - |
Tarek Hammami
CEO | Chief Executive Officer | - | - |
| Director/Board Member | - | 20-12-31 |
Adwya specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by activity as follows:
- sale of under licenses officinal medicines (50.9%);
- sale of generic officinal medicines (43.8%);
- sale of medicines to hospitals (2.2%);
- shaping services (0.8%): manufactured products packaging services ;
- other (0.1%).
The remaining sales (3%) are from international activities.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +18.57% | 22.25B | |
| +13.49% | 14.39B | |
| +12.83% | 13.55B | |
| +38.02% | 11.27B | |
| -10.10% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.35% | 5.01B | |
| -5.36% | 4.51B |
